T-cell regulation in murine and human autoimmune diabetes: The role of TH1 and TH2 cells

Diabetes and Metabolism

Volumn 23, Issue 5, 1997, Pages 377-385

  Hartemann Heurtier, A ^a   Boitard, C ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Immunotherapy; Insulin dependent diabetes mellitus; Protection; T helper 1; T helper 2

Indexed keywords

INSULIN;

AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; DRUG EFFECT; HELPER CELL; HUMAN; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNOTHERAPY; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH2 CELLS;

EID: 9844253891     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Mosmann TR, Schumacher JH, Street NF et al. Diversity of cytokine synthesis and function of mouse CD4 + T cells. Immunol Rev, 1991, 123, 209-229.
2. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol, 1995, 15, 3, 121-129.
3. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell, 1994, 76, 241-251.
4. Del Prete GF, De Carli M, Mastromauro C et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with a stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest, 1991, 88, 346-350.
5. Yamamura M, Uyemura K, Deans Rj et al. Defining protective responses to pathogens : cytokine profiles in leprosy lesions. Science, 1991, 254, 277-282.
6. Sher A, Gazzinelli RT, Oswald IP et al. Role of T cell derived cytokines on the down regulation of immune responses in parasitic and retroviral infection. Immunol Rev, 1992, 127, 183-204.
7. De Waal Malefyt R, Yssel H, De Vries JE. Direct effects of IL-10 on subsets of human CD4 + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol, 1993, 150, 4754-4765.
8. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon or interleukin 4 during the resolution or progression of murine leishmanias. Evidence for expansion of distinct helper T cell subsets. J Exp Med, 1989, 169, 59-72.
9. Sadick MD, Heinzel FP, Holaday BJ, Pu RT, Dawkins RS, Locksley RM. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferonγ-independent mechanism. J Exp J Med, 1990, 171, 115-127.
10. Heinzel FP, Rerko RM, Ahmed F, Pearlman E. Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice. J Immunol, 1995, 155, 730-739.
11. Maggi E, Parronchi P, Manetti R et al. Reciprocal regulatory effects of IFNγ and 1L-4 on the in vivo development of human Th1 and Th2 clones. J Immunol, 1992, 148, 2142-2147.
12. Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM. Development of TH1 CD4 + T cells through IL-12 produced by Leisteria-induced macrophages. Science, 1993, 260, 547-549.
13. Warrier R, Carvaial D, Wu C et al. Biological characterization of IL-12 p-40 knock-out mice. Exp Biol, 1995, abstract.
14. Manetti R, Parronchi P, Giudizi MG et al. Natural killer cell stimulatory factor (interleukin 12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med, 1993, 177, 1199-1204.
15. Murray JS, Madri J, Pasqualini T, Bottomly K. Functional CD4 + T cell subset interplay in an intact immune system. J Immunol, 1993, 150, 4270-4276.
16. Scott B, Liblau R, Degermann S et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity, 1994, 1, 73-82.
17. Carballido JM, Carballido-Perrig N, Terres G, Heusser CH, Blaser K. Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals : cytokine patterns change in response to the antigen concentation. Eur J Immunol, 1992, 22, 1357-1363.
18. Gajewski TF, Pinnas M, Wong T, Fitch FW. Murine TH1 and TH2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol, 1991, 146, 1750-1758.
19. Schmitz J, Assenmacher M, Radbruch A. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur J Immunol, 1993, 23, 191-199.
20. Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell, 1995, 80, 707-718.
21. Shanafelt M. C., Soderberg C, Allsup A, Adelman D, Peltz G, Lahesmaa R. Costimulatory signals can selectivly modulate cytokine production by subsets of CD4 + T cells. J. Immunol, 1995, 154, 1684-1690.
22. Del prete GF, De Carli M, D'Elios MM et al. CD30-mediated signalling promotes the development of human Th2-like T cells. J Exp Med, 1995, 182, 1-7.
23. Merril JE, Kono DH, Clayton J, Ando DG, Hinton DR, Hofman FM. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci USA, 1992, 89, 574-578.
24. Khoury SJ, Hancock WW, Weiner HL Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med, 1992, 176, 1355-1364.
25. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol, 1992, 149, 2496-2505.
26. Chen Y, Inobe J, Weiner HL. Induction of oral tolerance to myelin basic protein in CDS-depleted mice. J Immunol, 1995, 155, 910-916.
27. Goldman M, Druet P, Gleichmann E. TH2 cells in systemic autoimmunity: Insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today, 1991, 12, 223-227.
28. Gleeson PA, Toh BH, van Driel IR. Organ specific autoimmunity induced by lymphopenia. Immunol Reviews, 1996, 149, 97-125.
29. De Wit D, Van Mechelen M, Zanin C et al. Preferential activation of TH2 cells in chronic graft-versus-host reaction. J Immunol, 1993, 150, 361-365.
30. Ochel M, Vohr HW, Pfeiffer C, Gleishmann E. IL-4 is required for the IgE and IgG1 increase and IgG1 autoantibody formation in mice treated with mercuric chloride. J Immunol, 1991, 146, 3006-3011.
31. Romagnani S. TH1 and TH2 in human diseases. Clin Immunol Immunopathol, 1996, 80, 225-235.
32. Makino S, Kunimoto K, Muraoka Y, Tochino Y. Breeding of a non-obese diabetic strain. Exp. Anim, 1980, 29, 1-13.
33. Bedossa P, Bendelac A, Bach J.F, Camaud C. Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction. Eur J Immunol, 1989, 19, 1947-1951.
34. Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med, 1986, 314, 1360-1368.
35. Castano L, Eisenbarth GS. Type 1 diabetes : a chronic autoimmune disease of human, mouse, and rat. Ann Rev Immunol, 1990, 8, 647-679.
36. Shimada A, Charlton B, Taylor-Edwards C, Fathman CG. β cell destruction may be a late consequence of the autoimmune process in nonobese diabetic mice. Diabetes, 1996, 45, 1063-1067.
37. Boitard C, Yasunamy R, Dardenne M, Bach JF. T cell-mediated inhibition of the transfer of autoimmune diabetes in nod mice. J Exp Med, 1989, 169, 1669-1680.
38. Rohane PW, Shimada A, Kim DT et al. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/sicid mice. Diabetes, 1995, 44, 550-554.
39. Roll U, Christie MR, Fuchtenbusch M, Payton MA, Hawkes CJ, Ziegler AG. Perinatal autoimmunity in offspring of diabetic parents. Diabetes, 1996, 45, 967-973.
40. Verge CF, Gianani R, Kawasaki E et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes, 1996, 45, 926-933.
41. Leslie RDG, Pyke DA. Escaping insulin-dependent diabetes. Br Med J, 1991, 302, 1103-1104.
42. Shehadeh NN, Larosa F, Lafferty KJ. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun, 1993, 6, 291-300.
43. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF. IFNγ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol, 1994, 4874-4882.
44. Suarez-Pinzon W, Rajotte RV, Mosmann TR, Rabinovitch A. Both CD4 + and CD8 + T-cells in syngeneic islet grafts in NOD mice produce interferon-γ during β-cell destruction. Diabetes, 1996, 45, 1350-1357.
45. Anderson JT, Cornelius JG, Jarpe AJ, Wirter WE, Peck AB. Insulin-dependent diabetes in the NOD mouse model. II. β cell destruction in autoimmune diabetes is a Th2 and not a Th1 mediated event. Autoimmunity, 1993, 15, 113-122.
46. Rabinovitch A, Suarez-Pinzon W, El-Sheikh A, Sorensen O, Power RF. Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats. Expression of Th1 cytokines correlates with β-cell destructive insulitis and IDDM. Diabetes. 1996, 45, 749-754.
47. Kolb H, Pagenstert UW, Kleemann R, Rothe H, Rowsell P, Scott FW. Cytokine gene expression in the BB rat pancreas: natural course and impact of bacterial vaccines. Diabetologia, 1996, 39, 1448-1454.
48. Debray Sachs M, Carnaud C, Boitard C et al. Prevention of diabetes in NOD mice treated with antibody to murine IFNγ. J Autoimmun, 1991, 4, 237-248.
49. Sarvetnick N, Liggitt D, Pitts SL, Nansen SE, Stewart TA. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell, 1988, 52, 773-782.
50. Sarvetnick N, Shizuru J, Liggit D et al. Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature, 1990, 346, 844-847.
51. Von Herrath MG, Oldstone MBA. Interferon-γ is essential for destruction of β cells and development of insulin-dependent diabetes mellitus. J Exp Med, 1997, 185, 531-539.
52. Hultgren B, Huang X, Dybdal N, Stewart TA. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes, 1996, 45, 812-817.
53. Huang X, Yuan J, Goddard A et al. Interferon expression in the pancreases of patients with type I diabetes. Diabetes, 1995, 44, 658-663.
54. Haskins K, Portas M, Bradley B, Wegmann D, Lafferty K. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes, 1988, 37, 1044-1048.
55. Haskins K, Portas M, Brgman B, Lafferty K, Bradley B. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci USA, 1989, 86, 8000-8004.
56. Haskins K, Mc Duffie M. Acceleration of diabetes in young NOD mice with a CD4 + islet-specific T-cell clone. Science, 1990, 249, 1433-1436.
57. Haskins K, Wegmann D. Diabetogenic T-cell clones. Diabetes, 1996, 45, 1299-1305.
58. Katz Jd, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science, 1995, 268, 1185-1188.
59. Berman MA, Sandborg CI, Wang Z et al. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J Immunol, 1196, 157, 4690-4696.
60. Kallmann BA, Hüther M, Tubes M et al. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes, 1997, 46, 237-243.
61. Harrison LC, De Aizpurua H, Loudovaris T, et al. Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes, 1991, 40, 1128-1133.
62. Roep BO, Kallan AA, Duinkerken G, et al. T-cell reactivity to β-cell destruction in IDDM. Diabetes, 1995, 44, 278-283.
63. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, Mcdevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature, 1993, 366, 72-75.
64. Kaufman DL, Clare-Salzler M, Tian J et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature, 1993, 366, 69-71.
65. Tisch R, Yang XD, Liblau RS, McDevitt HO. Administering glutamic acid decarboxylase to NOD mice prevents diabetes. J Autoimmun, 1994, 7, 845-850.
66. Daniel D, Gill Rg, Schloot N, Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol, 1995, 25, 1056-1062.
67. Atkinson MA, Kaufman DL, Campbell L, et al. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet, 1992, 339, 458-459.
68. Harrison LC, Honeyman MC, Deaizpurua HJ et al. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet, 1993, 341, 1365-1369.
69. Panina-Bordignon P, Lang Rosmarie, Van Endert PM et al. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J Exp Med, 1995, 181, 1923-1927.
70. Roep BO. T-cell responses to autoantigens in IDDM. Diabetes, 1996, 45, 1147-1156.
71. Rapoport MJ, Jaramillo A, Zipris D et al. Interleukin 4 reverses T cell proliferative unresponsivness and prevents the onset of diabetes in nonobese diabetic mice. J Exp Med 1993, 178, 87-99.
72. Serreze DV, Hamaguchi K, Leiter EH. Immunostimulation circumvents diabetes in NOD /Lt mice. J Autoimmun, 1990, 2, 759-763.
73. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L. Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med, 1995, 181, 817-821.
74. Wogensen L, Lee MS, Sarvetnick N. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J Exp Med, 1994, 179, 1379-1384.
75. Moritani M, Yoshimoto K, Tashiro F et al. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int Immunol, 1994, 6, 12, 1927-1936.
76. Lee MS, Wogensen L Shizuru J, Oldstone MBA, Sarvetnick N. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J Clin Invest, 1994, 93, 1332-1338.
77. Moritani M, Yoshimoto K, Li S et al. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10 transduced islet-specific Th1 lymphocytes. J Clin Invest, 1996, 98, 1851-1859.
78. Tepper RI, Levinson DA, Stanger BZ, Campos-Torres J, Abbas AK, Leder P. IL4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell, 1990, 62, 457-467.
79. Imagawa A, Itoh N, Hanafusa T et al. Autoimmune endocrine disease induced by recombinant interferon-α therapy for chronic active type C hepatitis. J C E M, 1995, 80, 922-926.
80. Sadelain MWJ, Qin HY, Lauzon J, Singh B. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes, 1990, 583-589.
81. Qin HY, Sadlain MWJ, Hitchon C, Lauzon J, Singh B. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. J Immunol, 1993a, 150, 2072-2080.
82. Atkinson MA, Maclaren NK, Luchetta R. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes, 1990, 39, 933-937.
83. Thivolet CH, Goillot E, Bedossa P, Durand A, Bonnard M, Orgiazzi J. Insulin prevents adoptive cell transfer of diabetes in the autoimmune non-obese diabetic mouse. Diabetologia, 1991, 34, 314-319.
84. Muir A, Peck A, Clare-Salzer M et at. Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon gamma transcription. J Clin Invest, 1995, 95, 628-634.
85. Tisch R, Yang XD, Liblau RS, McDevitt HO. Administering glutamic acid decarboxylase to NOD mice prevents diabetes. J Autoimmun, 1994, 7, 845-850.
86. Kaufman DL, Clare-Salzler M, Tian J et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature, 1993, 366, 69-71.
87. Tian J, Clare-Salzler M, Herschenfeld A et al. Modulating autoimmune response to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nature medecine, 1996, 12, 1348-1353.
88. Keller RJ, Eisenbarth GS, Jackson RA. Insulin prophylaxis in individuals at high risk of type I diabetes. Lancet, 1993, 341, 927-928.
89. Gerstein H. Cow's milk exposure and type 1 diabetes mellitus Diabetes Care, 1994, 17, 13-19.
90. Karges W, Hammond-Mckibben D, Cheung RK et al. Immunological aspects of nutritional diabetes prevention in NOD mice. Diabetes, 1997, 46, 557-564.
91. Scott FW, Cloutier HE, Kleeman R et al. Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats. Diabetes, 1997, 46, 589-598.
92. Zhang ZJ, Davidson L, Eisenbarth G, Weiner HL. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc Natl Acad Sci USA, 1991, 88, 10252-10256.
93. Bergerot I, Fabien N, Maguer V, Thivolet C. Oral administration of human insulin to NOD mice generates CD4 + T-cells that suppress adoptive transfer of diabetes. J Autoimmun, 1994, 7, 655-663.
94. Hancock WW, Polanski M, Zhang J, Bloog N, Weiner HL. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin-E. Am J Pathol, 1995, 147, 1193-1199.
95. Tian BJ, Atkinson MA, Clare-Salzer M et al. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med, 1996, 183, 1561-1567.
96. Saï P, Rivereau AS. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Diabetes & Metabolism (Paris), 1996, 22, 341-348.
97. Bridoux F, Badou A, Saoudi A et al. Transforming growth factor β (TGF-β)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibilily complex (MHC) class II-specific, regulatory CD4 + T cell lines. J Exp Med, 1997, 185, 1769-1775.
98. Zekzer D, Wong S, Wen L et al. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes, 46, 1124-1132.
99. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vivo and in vitro immune responses by the release of TGF-β following antigenic specific triggering. Proc Natl Acad Sci USA, 1992, 89, 421-426.